Article information
Full text is only aviable in PDF
References
[1.]
K. Alving, E. Weitzberg, J.M. Lundberg.
Increased amount of nitric oxide in exhaled air of asthmatics.
Eur Respir J, 6 (1993), pp. 1368-1370
[2.]
S.A. Kharitonov, D. Yates, R.A. Robbins, R. Logan-Sinclair, E.A. Shinebourne, P.J. Barnes.
Increased nitric oxide in exhaled air of asthmatic patients.
Lancet, 343 (1994), pp. 133-135
[3.]
A. Jatakanon, S. Lim, S.A. Kharitonov, K.F. Chung, P.J. Barnes.
Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.
Thorax, 53 (1998), pp. 91-95
[4.]
A.C. Olin, B. Bake, K. Toren.
Fraction of exhaled nitric oxide at 50 ml/s: reference values for adult lifelong never-smokers.
Chest, 131 (2007), pp. 1852-1856
[5.]
J. Travers, S. Marsh, S. Aldington, M. Williams, P. Shirtcliffe, A. Pritchard, et al.
Reference ranges for exhaled nitric oxide derived from a random community survey of adults.
Am J Respir Crit Care Med, 176 (2007), pp. 238-242
[6.]
D.R. Taylor, M.W. Pijnenburg, A.D. Smith, J.C. De Jongste.
Exhaled nitric oxide measurements: clinical application and interpretation.
Thorax, 61 (2006), pp. 817-827
[7.]
A. Schneider, L. Tilemann, T. Schermer, L. Gindner, G. Laux, J. Szecsenyi, et al.
Diagnosing asthma in general practice with portable exhaled nitric oxide measurement–results of a prospective diagnostic study: FENO < or =16ppb better than FENO < or =12ppb to rule out mild and moderate to severe asthma [added].
Respir Res, 10 (2009), pp. 15
[8.]
S.L. Jones, J. Kittelson, J.O. Cowan, E.M. Flannery, R.J. Hancox, C.R. McLachlan, et al.
The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control.
Am J Respir Crit Care Med, 164 (2001), pp. 738-743
[9.]
A.F. Gelb, T.C. Flynn, C.M. Shinar, C. Gutierrez, N. Zamel.
Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.
Chest, 129 (2006), pp. 1492-1499
[10.]
H.L. Petsky, C.J. Cates, A. Li, J.A. Kynaston, C. Turner, A.B. Chang.
Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
Cochrane Database Syst Rev, (2009),
[11.]
A.D. Smith, J.O. Cowan, K.P. Brassett, G.P. Herbison, D.R. Taylor.
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.
N Engl J Med, 352 (2005), pp. 2163-2173
[12.]
D.E. Shaw, M.A. Berry, M. Thomas, R.H. Green, C.E. Brightling, A.J. Wardlaw, et al.
The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.
Am J Respir Crit Care Med, 176 (2007), pp. 231-237
[13.]
S.J. Szefler, H. Mitchell, C.A. Sorkness, P.J. Gergen, G.T. O’Connor, W.J. Morgan, et al.
Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.
Lancet, 372 (2008), pp. 1065-1072
[14.]
M. Malerba, B. Ragnoli, A. Radaeli, C. Tantucci.
Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma.
Chest, 134 (2008), pp. 733-739
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica
